MV PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MV PHARMA
Largest movements
- Receivables within one year +€35,862
up €35,862 (+15.0%), from €239,057 to €274,918
of which Other amounts receivable: +€40,229
- Cash -€23,660
down €23,660 (-88.9%), from €26,617 to €2,957
mainly Receivables within one year (-€35,862) and Other debts (-€12,599)
- Profit (loss) carried forward +€15,733
up €15,733 (+4.0%), from €389,950 to €405,683
- Other debts -€12,599
down €12,599 (-28.5%), from €44,137 to €31,538
- Trade debts +€6,309
up €6,309 (+2240.6%), from €282 to €6,591
- Gross operating margin +€18,992
up €18,992 (+451.1%), from €4,210 to €23,202
- Taxes +€3,636
up €3,636 (+266.5%), from €1,364 to €5,000
- Other operating charges -€493
down €493 (-51.0%), from €968 to €474
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €456,392 | €469,186 | +€12,795 | +2.8% |
| Fixed assets | 21/28 | €190,707 | €191,311 | +€604 | +0.3% |
| Tangible fixed assets | 22/27 | €2,758 | €3,363 | +€604 | +21.9% |
| Furniture and vehicles | 24 | €2,758 | €3,363 | +€604 | +21.9% |
| Financial fixed assets | 28 | €187,949 | €187,949 | = | 0.0% |
| Current assets | 29/58 | €265,685 | €277,875 | +€12,191 | +4.6% |
| Amounts receivable within one year | 40/41 | €239,057 | €274,918 | +€35,862 | +15.0% |
| Trade receivables | 40 | €12,393 | €8,025 | -€4,368 | -35.2% |
| Other amounts receivable | 41 | €226,664 | €266,893 | +€40,229 | +17.7% |
| Cash at bank and in hand | 54/58 | €26,617 | €2,957 | -€23,660 | -88.9% |
| Deferred charges and accrued income | 490/1 | €11 | - | -€11 | |
| Total equity and liabilities | 10/49 | €456,392 | €469,186 | +€12,795 | +2.8% |
| Equity | 10/15 | €410,410 | €426,143 | +€15,733 | +3.8% |
| Contributions | 10/11 | €20,460 | €20,460 | = | 0.0% |
| Profit (loss) carried forward | 14 | €389,950 | €405,683 | +€15,733 | +4.0% |
| Amounts payable | 17/49 | €45,982 | €43,044 | -€2,938 | -6.4% |
| Amounts payable within one year | 42/48 | €45,982 | €43,044 | -€2,938 | -6.4% |
| Trade debts | 44 | €282 | €6,591 | +€6,309 | +2240.6% |
| Suppliers | 440/4 | €282 | €6,591 | +€6,309 | +2240.6% |
| Taxes, remuneration and social security | 45 | €1,563 | €4,915 | +€3,352 | +214.4% |
| Taxes | 450/3 | €1,085 | €4,915 | +€3,830 | +353.0% |
| Remuneration and social security | 454/9 | €478 | - | -€478 | |
| Other amounts payable | 47/48 | €44,137 | €31,538 | -€12,599 | -28.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €133 | €339 | +€206 | +155.2% |
| Other operating charges | 640/8 | €968 | €474 | -€493 | -51.0% |
| Non-recurring operating charges | 66A | - | €1,519 | +€1,519 | |
| Gross operating margin | 9900 | €4,210 | €23,202 | +€18,992 | +451.1% |
| Operating profit (loss) | 9901 | €3,110 | €20,871 | +€17,761 | +571.2% |
| Financial charges | 65/66B | €212 | €137 | -€74 | -35.1% |
| Recurring financial charges | 65 | €212 | €137 | -€74 | -35.1% |
| Profit (loss) for the period before taxes | 9903 | €2,898 | €20,733 | +€17,835 | +615.5% |
| Income taxes | 67/77 | €1,364 | €5,000 | +€3,636 | +266.5% |
| Profit (loss) for the period | 9904 | €1,534 | €15,733 | +€14,200 | +925.9% |
| Profit (loss) for the period to be appropriated | 9905 | €1,534 | €15,733 | +€14,200 | +925.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.